Interstitial nephritis is an inflammatory kidney condition that targets the tissue surrounding your kidney’s filtering tubes (tubules) rather than the filters themselves. Unlike other forms of kidney disease that attack the glomeruli, the tiny filtering units of the kidney, interstitial nephritis inflames the supportive tissue and tubules while leaving those filters largely intact. It’s most commonly triggered by medications, and when caught early, about 76% of people recover kidney function within six months.
What Happens Inside the Kidney
Your kidneys contain millions of tiny tubes (tubules) that fine-tune what stays in your blood and what leaves as urine. These tubes are embedded in a layer of supportive tissue called the interstitium. In interstitial nephritis, immune cells flood into that supportive tissue, causing swelling and inflammation that compresses the tubules and their blood supply.
As the tissue swells, blood flow through the kidney decreases, and the organ’s overall filtering ability drops. If the inflammation persists, the body starts depositing collagen in the damaged areas, creating scar tissue (fibrosis). Once fibrosis sets in, the damage becomes harder to reverse. The glomeruli, which are typically the focus in other kidney diseases, stay relatively unaffected unless the condition becomes chronic.
Acute vs. Chronic Forms
The acute form develops over days to weeks, usually in response to a specific trigger like a new medication or infection. It often comes on suddenly, and kidney function can decline rapidly. If recognized and treated quickly, acute interstitial nephritis is frequently reversible.
Chronic interstitial nephritis develops gradually over months or years. It may result from prolonged exposure to a triggering substance, an untreated acute episode, or an ongoing autoimmune condition. By the time it’s detected, significant scarring may already be present, making full recovery less likely. Eventually, the glomeruli can become involved too, compounding the loss of kidney function.
Medications Are the Leading Cause
Drugs account for the majority of acute cases. NSAIDs like ibuprofen and naproxen are the single largest drug class responsible, causing roughly 44% of drug-induced cases. Antibiotics, particularly penicillins, cephalosporins, sulfonamides, and ciprofloxacin, account for about 33%. Proton pump inhibitors (PPIs) like omeprazole and lansoprazole are an increasingly recognized trigger, now considered the second most common drug cause in some studies, with an estimated incidence of 12 per 100,000 people.
The reaction isn’t dose-dependent. It’s an immune-mediated response, meaning it can happen at any dose and doesn’t necessarily occur the first time you take the drug. Other medication classes linked to interstitial nephritis include anti-seizure drugs like phenytoin, certain antivirals, and acid-reducing H2 blockers. The time between starting a medication and developing symptoms varies widely, which is part of what makes diagnosis tricky.
Non-Drug Triggers
Infections can cause interstitial nephritis, though less commonly than medications. Bacterial, viral, and fungal infections have all been implicated. Autoimmune diseases are another important category. Conditions like sarcoidosis, which produces clusters of inflammatory cells called granulomas, and IgG4-related disease can specifically target the kidney’s interstitial tissue. These non-drug causes tend to have lower recovery rates: about 66% achieve kidney recovery, compared to 81% for drug-related cases.
Symptoms Are Often Subtle
Many people expect interstitial nephritis to announce itself with obvious signs, and textbooks describe a “classic triad” of fever, skin rash, and elevated eosinophils (a type of white blood cell associated with allergic reactions). In practice, this triad appears in only about 6.5% of patients. That means the vast majority of people with interstitial nephritis don’t look like the textbook case.
More commonly, the condition is discovered when routine blood work shows a rising creatinine level, indicating declining kidney function. Some people notice changes in urine output, fatigue, nausea, or general malaise. Others have no noticeable symptoms at all. When a rash or fever does appear alongside a new medication and worsening kidney labs, it provides a helpful diagnostic clue, but its absence doesn’t rule anything out.
How It’s Diagnosed
Kidney biopsy remains the definitive way to confirm interstitial nephritis. Under a microscope, pathologists look for two hallmark findings: clusters of immune cells (lymphocytes, monocytes, and sometimes eosinophils) infiltrating the interstitial tissue, and “tubulitis,” where those inflammatory cells have invaded the walls of the tubules themselves. When eosinophils dominate the infiltrate, it raises suspicion of a drug reaction, though not all drug-induced cases show this pattern.
Biopsy can also identify specific non-drug causes. Sarcoidosis, for instance, produces distinctive granulomas visible under the microscope, while IgG4-related disease has its own characteristic staining pattern.
You may have heard of a urine test for eosinophils as a less invasive diagnostic option. Research from the Clinical Journal of the American Society of Nephrology found that this test performs poorly in practice. At the standard cutoff, urine eosinophils had only 31% sensitivity and 68% specificity for detecting interstitial nephritis, meaning the test misses most cases and frequently shows positive results in other kidney diseases. It essentially doesn’t shift the odds of diagnosis in either direction. Biopsy, while more invasive, provides far more reliable information.
Treatment and What to Expect
The first and most important step is removing the trigger. For drug-induced cases, this means stopping the offending medication. In many cases, kidney function begins to improve within days to weeks of withdrawal alone.
When kidney function doesn’t start recovering within one to two weeks of stopping the drug, corticosteroids may be considered. The typical approach involves a course of prednisone, sometimes preceded by a few days of higher-dose steroids given intravenously. The exact dose and duration vary, and research hasn’t shown a clear benefit to more aggressive steroid regimens. A large study of 182 steroid-treated cases found no added benefit from pulse-dose steroids or extended courses compared to standard treatment.
For cases caused by autoimmune conditions, treatment targets the underlying disease, which may require longer-term immunosuppressive therapy beyond steroids.
Recovery and Long-Term Outlook
The overall outlook is favorable when the condition is caught early. Roughly 76% of patients with biopsy-confirmed acute interstitial nephritis recover kidney function within six months. Drug-related cases fare best, with an 81% recovery rate compared to 66% for cases caused by infections or autoimmune conditions.
Two factors most strongly predict a poor outcome: significant scarring (fibrosis) already present on biopsy, and kidney function severe enough to require dialysis at the time of diagnosis. Both suggest the disease has progressed beyond early, reversible inflammation. Early suspicion matters. Patients whose doctors suspected interstitial nephritis before biopsy and acted accordingly had better outcomes than those diagnosed later in the process.
For those who don’t fully recover, the risk of progressing to chronic kidney disease is real. This is why delays in diagnosis are concerning. Interstitial nephritis is frequently confused with other causes of kidney injury, and the longer inflammation persists unchecked, the more scar tissue forms, making the damage permanent.